Skip Navigation

Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more

Marlise R. Luskin, MD, MSCE

Medical Oncology

Make an Appointment
Watch Video

Marlise R. Luskin, MD, MSCE


  • Associate Program Director, Dana-Farber/Mass General Brigham Hematology/Oncology Fellowship Program
  • Educational Director, Adult Leukemia Program
  • Senior Physician
  • Assistant Professor of Medicine, Harvard Medical School


Clinical Interests

  • Acute lymphoblastic leukemia (ALL)
  • Acute myeloid leukemia
  • Adolescents and young adults
  • Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
  • Chronic myelogenous leukemia
  • Hairy cell leukemia

Diseases Treated

Contact Information

  • Appointments617-632-1906
  • Office Phone Number617-632-1906
  • Fax617-632-5175


Dr. Luskin received her MD from the University of Pennsylvania Perelman School of Medicine in 2009. She completed residency training in Internal Medicine at Brigham and Women's Hospital and served as Chief Medical Resident in 2015. She completed her fellowship in Hematology and Oncology at the University of Pennsylvania where she also earned her Masters degree in clinical epidemiology and served as Chief Fellow. She joined Dana-Farber as a member of the Adult Leukemia program in 2016 where she focuses on the care of patients with acute and chronic leukemias with particular areas of interest including acute lymphoblastic leukemia, acute myeloid leukemia, chronic myeloid leukemia, blastic plasmacytoid dendritic cell neoplasm, and the care of young adults with acute and chronic leukemias. Dr. Luskin is also active in leading clinical trials and serves as the associate program director of the Dana-Farber/Mass General Brigham Hematology/Oncology Fellowship Program and education director for the adult leukemia program.


Marlise Luskin, MD, MSCE, is a physician in Dana-Farber’s Adult Leukemia program. She treats patients with acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), myelodysplastic syndrome and a number of other blood cancers. Luskin discusses her approach to a patient’s first visit, and helping patients understand their disease and treatment options. Learn more about the leukemia program:

Board Certification:

  • Hematology, 2015
  • Internal Medicine, 2012
  • Medical Oncology, 2015


  • University of Pennsylvania, Hematology/Oncology


  • Brigham and Women's Hospital, Chief Medical Resident
  • Brigham and Women's Hospital, Internal Medicine

Medical School:

  • University of Pennsylvania School of Medicine


Dana-Farber Cancer Institute
450 Brookline Avenue
Boston, MA 02215
Get Directions